Cited by 167Cancer, Hypoxia, and MetabolismDiabetes Management and ResearchPancreatic function and diabetes

Hypoxia-inducible factors and diabetes

Open access
Gunton, Jenny E.·2020·Journal of Clinical Investigation

Abstract

Hypoxia can be defined as a relative deficiency in the amount of oxygen reaching the tissues. Hypoxia-inducible factors (HIFs) are critical regulators of the mammalian response to hypoxia. In normal circumstances, HIF-1α protein turnover is rapid, and hyperglycemia further destabilizes the protein. In addition to their role in diabetes pathogenesis, HIFs are implicated in development of the microvascular and macrovascular complications of diabetes. Improving glucose control in people with diabetes increases HIF-1α protein and has wide-ranging benefits, some of which are at least partially mediated by HIF-1α. Nevertheless, most strategies to improve diabetes or its complications via regulation of HIF-1α have not currently proven to be clinically useful. The intersection of HIF biology with diabetes is a complex area in which many further questions remain, especially regarding the well-conducted studies clearly describing discrepant effects of different methods of increasing HIF-1α, even within the same tissues. This Review presents a brief overview of HIFs; discusses the range of evidence implicating HIFs in β cell dysfunction, diabetes pathogenesis, and diabetes complications; and examines the differing outcomes of HIF-targeting approaches in these conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci137556

Cites

161 of 162 references verified0 citation errors · 1 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysregulated HIF signaling contributes to the pathogenesis of metabolic diseases, including diabetes mellitus and its complications.

    “Importantly, dysregulated HIF signaling also contributes to the pathogenesis of metabolic diseases, including diabetes mellitus and its complications [231,232].”

    From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [231]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

1 of the 163 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Gunton, J. E.
Affiliations
The University of Sydney (AU)
Corresponding author
Gunton, Jenny E.
Venue
Journal of Clinical Investigation
Published
2020-09-14
Volume
130
Issue
10
Pages
5063-5073
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W3071274483
Cited by
159
References
163
Citations by year
2026: 22 · 2025: 24 · 2024: 25 · 2023: 40 · 2022: 33 · 2021: 15
FWCI
2.40
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
NHMRC (AppID1149976)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
hypoxia-inducible factor, HIF-1α, diabetes pathogenesis, hypoxia, hyperglycemia, beta-cell dysfunction, diabetes complications, microvascular complications, macrovascular complications, glycemic control
MeSH terms
Endothelial PAS Domain-Containing Protein 1, Animals, Diabetes Mellitus, Glucose, Humans, Models, Biological, Tissue Distribution, Diabetes Complications, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review